News Office (The Jakarta Post)
Tokyo, Japan ●
Sun, October 9, 2022
The Indonesian Chamber of Commerce (KADIN) is pushing for greater collaboration between Indonesia and Japan in pharmaceutical and medical devices as part of the country’s efforts to strengthen global health cooperation under the Group of Twenty (G20).
As part of that effort, KADIN last week sent a 15-member delegation, including representatives from nine of Indonesia’s pharmaceutical and medical device manufacturers, to meet with their Japanese counterparts.
One of the results of the series of meetings with Japanese business groups was the signing of an undertaking between the Indonesian Association of Pharmaceutical Companies (GPFI) and the Association of Medical Equipment Manufacturers (ASPAKI) with the Federation of Pharmaceutical Manufacturers Associations of Japan (FPMAJ).
“FPMAJ is honored to be a part of it, and we look forward to continuing our collaboration with Indonesia in medical fields,” said FPMAJ Director General Toshihiko Miyajima.
Director of the Food and Drugs Monitoring Agency (BPOM), Penny Lukito, said the Indonesian government fully supports the collaboration.
“The Indonesian market is an important factor that could attract Japanese investors. I therefore invite Japanese pharmaceutical players to collaborate more with Indonesia through research and development of technology-based drugs,” he said. said Penny in her speech.
Indonesia’s pharmaceuticals and medical devices sector is worth US$10.1 billion in 2021 and is expected to grow in the coming year as the middle class expands.
The Indonesian Embassy in Tokyo said collaboration between Indonesia and Japan could be further strengthened, especially within the framework of the G20.
“Today’s event is the achievement of one of the G20 pillars in global health collaboration,” said Indonesian Ambassador to Japan Heri Akhmadi.